Eurobio Scientific SA (ALERS):企業の製品パイプライン分析

◆英語タイトル:Eurobio Scientific SA (ALERS) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME7843PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer’s disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Eurobio Scientific SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Eurobio Scientific SA Company Overview
Eurobio Scientific SA Company Snapshot
Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
Eurobio Scientific SA – Pipeline Analysis Overview
Eurobio Scientific SA – Key Facts
Eurobio Scientific SA – Major Products and Services
Eurobio Scientific SA Pipeline Products by Development Stage
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA Pipeline Products Overview
CO-3S Companion Diagnostic Assay
CO-3S Companion Diagnostic Assay Product Overview
Companion Diagnostic Test – Breast Cancer
Companion Diagnostic Test – Breast Cancer Product Overview
DHT Dx15
DHT Dx15 Product Overview
DHT Dx15 Clinical Trial
DIAG-3S Diagnostic Assay
DIAG-3S Diagnostic Assay Product Overview
Disease Evolution Predictive Test – AIDS
Disease Evolution Predictive Test – AIDS Product Overview
EHT Dx 11
EHT Dx 11 Product Overview
EHT Dx 12
EHT Dx 12 Product Overview
EHT Dx13
EHT Dx13 Product Overview
EHT Dx14
EHT Dx14 Product Overview
EHT Dx23
EHT Dx23 Product Overview
T-COR 8 – Dengue Fever
T-COR 8 – Dengue Fever Product Overview
T-COR 8 – Meningitis
T-COR 8 – Meningitis Product Overview
Therapeutic Drug Monitoring Test – Resistant Cancer
Therapeutic Drug Monitoring Test – Resistant Cancer Product Overview
VAC-3S Companion Diagnostic Test
VAC-3S Companion Diagnostic Test Product Overview
Eurobio Scientific SA – Key Competitors
Eurobio Scientific SA – Key Employees
Eurobio Scientific SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Eurobio Scientific SA, Recent Developments
Oct 15, 2019: Eurobio Scientific: Strong earnings growth for the first half of 2019
Jul 23, 2019: Eurobio Scientific’s activity for the first half of 2019: Strong growth of sales
Jan 29, 2019: Eurobio Scientific reaches the €50m sales mark in 2018
Jul 23, 2018: Eurobio Scientific: 2018 mid-year activity report
Jun 30, 2018: Eurobio Scientific announce 2018 mid year results
Feb 15, 2018: Diaxonhit: Exclusive distribution of the VERIGENE molecular biology platform
Mar 24, 2016: Diaxonhit: Further progress of commercial activity Initial sales of proprietary products
Jan 26, 2016: Diaxonhit: 2015 Consolidated Income: €29.5 M
Sep 24, 2015: Diaxonhit: 2015 mid-year results
Jul 30, 2015: Encouraging results of the first clinical study of the VAC-3S vaccine against HIV, for which DIAXONHIT develops Companion Diagnostic Assay CO-3S
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
Eurobio Scientific SA Pipeline Products by Equipment Type
Eurobio Scientific SA Pipeline Products by Indication
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA, Key Facts
Eurobio Scientific SA, Major Products and Services
Eurobio Scientific SA Number of Pipeline Products by Development Stage
Eurobio Scientific SA Pipeline Products Summary by Development Stage
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA Ongoing Clinical Trials Summary
CO-3S Companion Diagnostic Assay - Product Status
CO-3S Companion Diagnostic Assay - Product Description
Companion Diagnostic Test - Breast Cancer - Product Status
Companion Diagnostic Test - Breast Cancer - Product Description
DHT Dx15 - Product Status
DHT Dx15 - Product Description
DHT Dx15 - Clinical Validation of the Diagnostic Performance of a Molecular Signature to Determine the Malignant or Benign Profile of a Thyroid Nodule with Indeterminate Cytological Analysis
DIAG-3S Diagnostic Assay - Product Status
DIAG-3S Diagnostic Assay - Product Description
Disease Evolution Predictive Test - AIDS - Product Status
Disease Evolution Predictive Test - AIDS - Product Description
EHT Dx 11 - Product Status
EHT Dx 11 - Product Description
EHT Dx 12 - Product Status
EHT Dx 12 - Product Description
EHT Dx13 - Product Status
EHT Dx13 - Product Description
EHT Dx14 - Product Status
EHT Dx14 - Product Description
EHT Dx23 - Product Status
EHT Dx23 - Product Description
T-COR 8 - Dengue Fever - Product Status
T-COR 8 - Dengue Fever - Product Description
T-COR 8 - Meningitis - Product Status
T-COR 8 - Meningitis - Product Description
Therapeutic Drug Monitoring Test - Resistant Cancer - Product Status
Therapeutic Drug Monitoring Test - Resistant Cancer - Product Description
VAC-3S Companion Diagnostic Test - Product Status
VAC-3S Companion Diagnostic Test - Product Description
Eurobio Scientific SA, Key Employees
Eurobio Scientific SA, Other Locations
Eurobio Scientific SA, Subsidiaries
Glossary

★海外企業調査レポート[Eurobio Scientific SA (ALERS):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virbac Corporation
    Virbac Corporation - Strategy, SWOT and Corporate Finance Report Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Japan Tobacco Inc.:企業の戦略・SWOT・財務情報
    Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • San Miguel Brewery Hong Kong Ltd.:企業の戦略・SWOT・財務分析
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Otto Bock HealthCare GmbH-医療機器分野:企業M&A・提携分析
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • The British Land Company PLC:企業の戦略・SWOT・財務分析
    The British Land Company PLC - Strategy, SWOT and Corporate Finance Report Summary The British Land Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Reata Pharmaceuticals Inc (RETA):製薬・医療:M&Aディール及び事業提携情報
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • Entek Energy Ltd (ETE):石油・ガス:M&Aディール及び事業提携情報
    Summary Entek Energy Limited (Entek Energy) is an upstream energy company that carries out the exploration, production and development of oil and gas reserves in addition to investment in the energy resources industry. It acquires oil and gas assets and explores conventional and unconventional sourc …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • Mayo Clinic-製薬・医療分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Scatec Solar ASA (SSO):電力:M&Aディール及び事業提携情報
    Summary Scatec Solar ASA (Scatec Solar) is an integrated independent producer of solar power that develops, builds, owns and operates solar power plants. It conducts project origination and development, project financing, design and engineering, procurement and construction management, operation and …
  • Aspect Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aspect Imaging Inc (Aspect Imaging) is a medical device company that develops and manufactures magnetic resonance imaging systems. The company’s products comprise wristview medical systems, preclinical, process control, oil and gas analyzers, NMR, materials MRI and software. It offers precli …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Fujirebio Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that develops, manufactures and markets in-vitro diagnostic products and biomarker assays. The company’s products include manual kits, EIA kits, OEM custom solutions, multi-constituent controls, …
  • Bank Zachodni WBK SA:戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Determine Inc (DTRM):企業の財務・戦略的SWOT分析
    Summary Determine Inc (Determine), formerly Selectica Inc and a subsidiary of Corcentric, is a technology company. The company provides SaaS source-to-pay and enterprise contract lifecycle management solutions. It offers solutions such as strategic sourcing, supplier management; procure to pay, invo …
  • Electronic Control Security Inc.:企業の戦略・SWOT・財務情報
    Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆